Literature DB >> 18439948

Acyclovir plus steroid vs steroid alone in the treatment of Bell's palsy.

Seung Geun Yeo1, Young Chan Lee, Dong Choon Park, Chang Il Cha.   

Abstract

PURPOSE: The pathogenetic mechanism of Bell's palsy is thought to involve herpes simplex virus reactivation within the geniculate ganglion, followed by inflammation and entrapment of the nerve at the meatal foramen. We therefore compared the therapeutic effect of acyclovir plus steroid vs steroid alone, in combination with physical therapy, in patients with Bell's palsy.
MATERIALS AND METHODS: In a double-blind, randomized, prospective trial, 91 patients were randomized to treatment with acyclovir and prednisone (44 patients) or prednisone alone (47 patients). All patients underwent physical therapy. The follow-up period was greater than 6 months or encompassed the period of complete recovery from paralysis. House-Brackmann grade was evaluated 2 and 6 months after onset, with complete and satisfactory recovery defined as House-Brackmann grades I and II, respectively.
RESULTS: The overall recovery rate of patients treated with steroid and acyclovir (93.1%) was greater than that of patients treated with steroid alone (85.1%), but the difference was not statistically significant.
CONCLUSION: The benefit of acyclovir in Bell's palsy has not been definitively established.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439948     DOI: 10.1016/j.amjoto.2007.05.001

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  13 in total

1.  [Idiopathic facial palsy].

Authors:  M Grosheva; D Beutner; G F Volk; C Wittekindt; O Guntinas-Lichius
Journal:  HNO       Date:  2010-05       Impact factor: 1.284

Review 2.  Neuro-ophthalmologic complications and manifestations of upper and lower motor neuron facial paresis.

Authors:  M Tariq Bhatti; Jade S Schiffman; Anastas F Pass; Rosa A Tang
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

3.  Comparison of acyclovir and famciclovir for the treatment of Bell's palsy.

Authors:  Ho Joong Kim; Sang Hoon Kim; Junyang Jung; Sung Su Kim; Jae Yong Byun; Moon Suh Park; Seung Geun Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-12       Impact factor: 2.503

4.  Steroid-antivirals treatment versus steroids alone for the treatment of Bell's palsy: a meta-analysis.

Authors:  Yabing Dong; Yong Zhu; Chuan Ma; Huaqiang Zhao
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Prognosis of patients with recurrent facial palsy.

Authors:  Dae Han Chung; Dong Choon Park; Jae Yong Byun; Moon Suh Park; So Yoon Lee; Seung Geun Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-30       Impact factor: 2.503

6.  Corticosteroid and antiviral therapy for Bell's palsy: a network meta-analysis.

Authors:  Pawin Numthavaj; Ammarin Thakkinstian; Charungthai Dejthevaporn; John Attia
Journal:  BMC Neurol       Date:  2011-01-05       Impact factor: 2.474

7.  Antiviral treatment for Bell's palsy (idiopathic facial paralysis).

Authors:  Ildiko Gagyor; Vishnu B Madhok; Fergus Daly; Frank Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

Review 8.  The neurologist's dilemma: a comprehensive clinical review of Bell's palsy, with emphasis on current management trends.

Authors:  Anthony Zandian; Stephen Osiro; Ryan Hudson; Irfan M Ali; Petru Matusz; Shane R Tubbs; Marios Loukas
Journal:  Med Sci Monit       Date:  2014-01-20

9.  Nerve growth factor for Bell's palsy: A meta-analysis.

Authors:  Yipeng Su; Xiaomeng Dong; Juan Liu; Yaozhi Hu; Jinbo Chen
Journal:  Exp Ther Med       Date:  2014-12-03       Impact factor: 2.447

Review 10.  The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis.

Authors:  Eudocia C Quant; Shafali S Jeste; Rajeev H Muni; Alison V Cape; Manveen K Bhussar; Anton Y Peleg
Journal:  BMJ       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.